Further logistic regression analysis revealed that, after controlling for maternal age, BMI, gestational age, mode of delivery, labor duration, and pregnancy complications, high-dose oxytocin significantly increased the risk of neonatal hyperbilirubinemia, with moderate-dose exposure also elevating risk. The gene discussed is OXT; the disease is Hyperbilirubinemia.